Ashley Cordova Novo Cure LTD (NVCR) insider trading activity

Ashley Cordova is Chief Financial Officer of NovoCure Ltd. Currently has a direct ownership of 219,179 shares of NVCR, which is worth approximately $3.7 Million. The most recent transaction as insider was on Aug 02, 2024, when has been sold 688 shares (Ordinary Shares) at a price of $20.14 per share, resulting in proceeds of $13,856. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 219K

0% 3M change

86.35% 12M change

Total Value Held $3.7 Million

Ashley Cordova Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 02 2024	SELL Open market or private sale	$13,856 $20.14 p/Share	688 Reduced 0.31%	219,179 Ordinary Shares
Jun 28 2024	BUY Grant, award, or other acquisition	$15,740 $12.24 p/Share	1,286 Added 0.58%	220,465 Ordinary Shares
Feb 27 2024	BUY Grant, award, or other acquisition	$1,666,658 $16.3 p/Share	102,249 Added 31.74%	219,867 Ordinary Shares
Nov 02 2023	BUY Exercise of conversion of derivative security	$2,005 $11.46 p/Share	175 Added 0.15%	117,618 Ordinary Shares
Oct 31 2023	BUY Exercise of conversion of derivative security	$178,285 $10.02 p/Share	17,793 Added 13.16%	117,443 Ordinary Shares
Sep 01 2023	SELL Open market or private sale	$19,267 $21.82 p/Share	883 Reduced 0.88%	99,650 Ordinary Shares
Aug 02 2023	SELL Open market or private sale	$34,606 $30.25 p/Share	1,144 Reduced 1.13%	100,533 Ordinary Shares
Jun 30 2023	BUY Grant, award, or other acquisition	$12,947 $35.28 p/Share	367 Added 0.36%	101,677 Ordinary Shares
Mar 03 2023	SELL Open market or private sale	$419,260 $76.16 p/Share	5,505 Reduced 5.15%	101,310 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	11,808 Added 9.95%	106,815 Ordinary Shares
Mar 02 2023	SELL Open market or private sale	$79,420 $75.28 p/Share	1,055 Reduced 1.1%	95,007 Ordinary Shares
Mar 01 2023	SELL Open market or private sale	$167,839 $76.36 p/Share	2,198 Reduced 2.24%	96,062 Ordinary Shares
Feb 28 2023	BUY Grant, award, or other acquisition	-	23,818 Added 19.51%	98,260 Ordinary Shares
Jan 06 2023	BUY Grant, award, or other acquisition	$4,111 $62.3 p/Share	66 Added 0.09%	74,442 Ordinary Shares
Dec 02 2022	BUY Exercise of conversion of derivative security	$14,300 $7.15 p/Share	2,000 Added 2.62%	74,376 Ordinary Shares
Sep 02 2022	SELL Open market or private sale	$69,950 $79.04 p/Share	885 Reduced 1.21%	72,376 Ordinary Shares
Aug 02 2022	BUY Grant, award, or other acquisition	$499,964 $70.2 p/Share	7,122 Added 8.86%	73,261 Ordinary Shares
Jul 05 2022	BUY Grant, award, or other acquisition	$14,829 $59.08 p/Share	251 Added 0.38%	66,139 Ordinary Shares
Mar 08 2022	SELL Open market or private sale	$53,206 $70.1 p/Share	759 Reduced 1.23%	60,848 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$39,148 $70.41 p/Share	556 Reduced 0.89%	61,607 Ordinary Shares
Mar 03 2022	SELL Open market or private sale	$85,600 $74.5 p/Share	1,149 Reduced 1.81%	62,163 Ordinary Shares
Mar 03 2022	BUY Exercise of conversion of derivative security	$68,191 $13.53 p/Share	5,040 Added 7.11%	65,888 Ordinary Shares
Mar 03 2022	BUY Grant, award, or other acquisition	-	21,508 Added 25.36%	63,312 Ordinary Shares
Jan 06 2022	BUY Grant, award, or other acquisition	$2,936 $63.82 p/Share	46 Added 0.11%	41,804 Ordinary Shares
Nov 02 2021	SELL Open market or private sale	$22,422 $107.28 p/Share	209 Reduced 0.5%	41,758 Ordinary Shares

Ashley Cordova

Chief Financial Officer

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Value

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NovoCure Ltd

Track Activities on NVCR

Account